David D. Chang - Jan 24, 2025 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Signature
/s/Earl Douglas, Attorney-in-Fact
Stock symbol
ALLO
Transactions as of
Jan 24, 2025
Transactions value $
$0
Form type
4
Date filed
1/28/2025, 08:10 PM
Previous filing
May 20, 2024
Next filing
Feb 5, 2025

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALLO Stock Option (Right to buy) Award $0 +1.95M $0.00 1.95M Jan 24, 2025 Common Stock 1.95M $1.94 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 960 shares of the Issuer's common stock acquired by the reporting person on September 15, 2024 pursuant to an employee stock purchase program.
F2 Securities held in the name of the RTC 2019 Trust dated October 1, 2019.
F3 Securities held in the name of the JEC 2019 Trust dated October 1, 2019.
F4 Securities held in the name of the Chang 2006 Family Trust
F5 25% of the shares subject to the stock option shall vest on January 24, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter.

Remarks:

Exhibits: Power of Attorney